Comments to FDA: Recordkeeping Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002

Share page:

Comments | Jul 7, 2003

Docket Number:
02N-0277

CHPA seeks clarification concerning FDA’s interpretation of the recordkeeping requirement as applied to packaging manufacturers and distributors.

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement Regarding ODSP Leadership

Press Releases and Statements

CHPA Applauds the Re-introduction of Bipartisan CBD Legislation